Researchers set out to determine whether attention-deficit/hyperactivity disorder predisposes individuals to the development of neuropsychiatric symptoms. The researchers presented their findings at the...
Researchers sought to determine the efficacy of brexpiprazole in reducing agitation symptoms in patients with dementia due to Alzheimer disease. The results were presented at the Alzheimer Association...
Researchers used data from the Alzheimer's Disease Neuroimaging Initiative database to identify specific brain regions associated with hyperactive neuropsychiatric symptoms among patients with mild...
Researchers examining patients with late-stage dementia and significant agitation, found that a wearable device such as a wrist-worn actigraphy could be a feasible behavior-monitoring tool to assess sleep...
Researchers compared clinical characteristics, health care costs, and mortality outcomes among patients with Alzheimer dementia with and without agitation.
Researchers set out to determine the associations between self- and partner-reported cognitive decline and tau and β-amyloid levels among cognitively unimpaired individuals.
A recent cross-sectional, observational study compared the tau spread in people with Down syndrome and autosomal-dominant Alzheimer disease to identify tau-related differences between the two groups.
A retrospective cohort study comparing thick and thin liquid diets for patients with Alzheimer disease and related dementias (ADRD) and dysphagia yielded mixed results.
